Bruker (BRKR) EBITDA Margin: History & Chart

Bruker Corporation(BRKR)

Medical - Devices · Billerica, MA

$61.47-2.39 (-3.74%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Bruker Corporation

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.

Billerica, MA

11,085 employees

www.bruker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Frank H. Laukien

View full financials

BRKR EBITDA Margin Metrics

EBITDA MARGIN

13.28%

EBITDA MARGIN AVG TTM

9.63%

EBITDA MARGIN AVG 3Y

13.71%

EBITDA MARGIN AVG 5Y

16.61%

EBITDA MARGIN AVG 10Y

16.56%

EBITDA MARGIN AVG 15Y

14.48%

EBITDA MARGIN AVG 20Y

13.94%

CURRENT VS TTM AVG

+37.96%

CURRENT VS 3Y AVG

-3.12%

CURRENT VS 5Y AVG

-20.03%

CURRENT VS 10Y AVG

-19.83%

CURRENT VS 15Y AVG

-8.28%

CURRENT VS 20Y AVG

-4.71%

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
Bruker Corporation (BRKR)	$9.36B	13.28%	9.63%	13.71%	16.61%
Insulet Corp. (PODD)vs ›	$9.37B	21.67%	20.24%	16.36%	15.66%
Krystal Biotech, Inc. (KRYS)vs ›	$9.48B	43.13%	34.03%	-45.57%	-45.57%
Bruker Corporation (BRKRP)vs ›	$9.10B	13.28%	13.13%	16.37%	17.13%
Henry Schein, Inc. (HSIC)vs ›	$9.72B	8.11%	8.11%	8.28%	8.19%
Axsome Therapeutics, Inc. (AXSM)vs ›	$8.83B	-25.09%	-47.89%	-132.36%	-132.36%
The Ensign Group, Inc. (ENSG)vs ›	$10.05B	10.47%	10.43%	10.38%	10.85%
Molina Healthcare, Inc. (MOH)vs ›	$10.08B	2.15%	3.41%	4.20%	4.49%
Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›	$8.56B	14.74%	-8194.33%	-4134.44%	-2789.78%
Caris Life Sciences, Inc. (CAI)vs ›	$8.54B	8.34%	-21.08%	-58.51%	-29.82%

NAME

MARKET CAP

EBITDA MARGIN

TTM

Bruker Corporation (BRKR)

$9.36B

13.28%

9.63%

13.71%

16.61%

Insulet Corp. (PODD)vs ›

$9.37B

21.67%

20.24%

16.36%

15.66%

Krystal Biotech, Inc. (KRYS)vs ›

$9.48B

43.13%

34.03%

-45.57%

Bruker Corporation (BRKRP)vs ›

$9.10B

13.28%

13.13%

16.37%

17.13%

Henry Schein, Inc. (HSIC)vs ›

$9.72B

8.11%

8.28%

8.19%

Axsome Therapeutics, Inc. (AXSM)vs ›

$8.83B

-25.09%

-47.89%

-132.36%

The Ensign Group, Inc. (ENSG)vs ›

$10.05B

10.47%

10.43%

10.38%

10.85%

Molina Healthcare, Inc. (MOH)vs ›

$10.08B

2.15%

3.41%

4.20%

4.49%

Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›

$8.56B

14.74%

-8194.33%

-4134.44%

-2789.78%

Caris Life Sciences, Inc. (CAI)vs ›

$8.54B

8.34%

-21.08%

-58.51%

-29.82%

EBITDA Margin FAQ

What is the EBITDA margin for Bruker Corporation (BRKR)?

The EBITDA margin for BRKR stock is 13.28%.

Is Bruker Corporation's EBITDA margin high or low?

The EBITDA margin of 13.28% is 20% below its 5-year average of 16.61%, around the middle of its 5-year range (-0.87%–24.34%).

What is the TTM average EBITDA margin for Bruker Corporation (BRKR)?

The TTM average EBITDA margin for BRKR stock is 9.63%.

What is the 3Y average EBITDA margin for Bruker Corporation (BRKR)?

The 3Y average EBITDA margin for BRKR stock is 13.71%.

What is the 5Y average EBITDA margin for Bruker Corporation (BRKR)?

The 5Y average EBITDA margin for BRKR stock is 16.61%.

What is the 10Y average EBITDA margin for Bruker Corporation (BRKR)?

The 10Y average EBITDA margin for BRKR stock is 16.56%.

What is the 15Y average EBITDA margin for Bruker Corporation (BRKR)?

The 15Y average EBITDA margin for BRKR stock is 14.48%.

What is the 20Y average EBITDA margin for Bruker Corporation (BRKR)?

The 20Y average EBITDA margin for BRKR stock is 13.94%.

DATE	EBITDA MARGIN
2026-06-30	-0.87%
2026-03-31	12.55%
2025-12-31	17.39%
2025-09-30	10.54%
2025-06-30	8.53%
2025-03-31	10.26%
2024-12-31	12.76%
2024-09-30	13.78%
2024-06-30	11.65%
2024-03-31	13.79%
2023-12-31	16.48%
2023-09-30	20.34%
2023-06-30	16.44%
2023-03-31	21.57%
2022-12-31	21.95%
2022-09-30	24.34%
2022-06-30	16.23%
2022-03-31	19.87%
2021-12-31	22.66%
2021-09-30	22.24%
2021-06-30	18.78%
2021-03-31	20.08%
2020-12-31	23.79%
2020-09-30	19.89%
2020-06-30	13.87%
2020-03-31	8.35%
2019-12-31	23.07%
2019-09-30	20.48%
2019-06-30	14.87%
2019-03-31	13.20%
2018-12-31	22.22%
2018-09-30	18.22%
2018-06-30	14.74%
2018-03-31	12.49%
2017-12-31	20.62%
2017-09-30	15.38%
2017-06-30	11.93%
2017-03-31	13.69%
2016-12-31	19.31%
2016-09-30	15.13%
2016-06-30	9.12%
2016-03-31	12.57%
2015-12-31	17.57%
2015-09-30	10.48%
2015-06-30	11.31%
2015-03-31	8.12%
2014-12-31	11.14%
2014-09-30	5.36%
2014-06-30	10.98%
2014-03-31	8.45%
2013-12-31	13.93%
2013-09-30	10.64%
2013-06-30	12.86%
2013-03-31	6.96%
2012-12-31	10.79%
2012-09-30	16.57%
2012-06-30	8.82%
2012-03-31	11.83%
2011-12-31	14.17%
2011-09-30	9.15%
2011-06-30	9.82%
2011-03-31	8.29%
2010-12-31	15.36%
2010-09-30	12.99%
2010-06-30	12.83%
2010-03-31	12.39%
2009-12-31	23.20%
2009-09-30	12.49%
2009-06-30	10.77%
2009-03-31	9.15%
2008-12-31	17.87%
2008-09-30	9.47%
2008-06-30	9.13%
2008-03-31	16.57%
2007-12-31	18.21%
2007-09-30	9.06%
2007-06-30	5.78%
2007-03-31	7.37%
2006-12-31	21.55%
2006-09-30	8.51%
2006-06-30	4.67%
2006-03-31	5.32%
2005-12-31	15.97%
2005-09-30	4.62%
2005-06-30	1.28%
2005-03-31	3.97%
2004-12-31	2.71%
2004-09-30	0.38%
2004-06-30	-8.23%
2004-03-31	2.88%
2003-12-31	15.98%
2003-09-30	-1.99%
2003-06-30	0.99%
2003-03-31	9.76%
2002-12-31	20.90%
2002-09-30	8.95%

DATE

EBITDA MARGIN

2026-06-30

-0.87%

2026-03-31

12.55%

2025-12-31

17.39%

2025-09-30

10.54%

2025-06-30

8.53%

2025-03-31

10.26%

2024-12-31

12.76%

2024-09-30

13.78%

2024-06-30

11.65%

2024-03-31

13.79%

2023-12-31

16.48%

2023-09-30

20.34%

2023-06-30

16.44%

2023-03-31

21.57%

2022-12-31

21.95%

2022-09-30

24.34%

2022-06-30

16.23%

2022-03-31

19.87%

2021-12-31

22.66%

2021-09-30

22.24%

2021-06-30

18.78%

2021-03-31

20.08%

2020-12-31

23.79%

2020-09-30

19.89%

2020-06-30

13.87%

2020-03-31

8.35%

2019-12-31

23.07%

2019-09-30

20.48%

2019-06-30

14.87%

2019-03-31

13.20%

2018-12-31

22.22%

2018-09-30

18.22%

2018-06-30

14.74%

2018-03-31

12.49%

2017-12-31

20.62%

2017-09-30

15.38%

2017-06-30

11.93%

2017-03-31

13.69%

2016-12-31

19.31%

2016-09-30

15.13%

2016-06-30

9.12%

2016-03-31

12.57%

2015-12-31

17.57%

2015-09-30

10.48%

2015-06-30

11.31%

2015-03-31

8.12%

2014-12-31

11.14%

2014-09-30

5.36%

2014-06-30

10.98%

2014-03-31

8.45%

2013-12-31

13.93%

2013-09-30

10.64%

2013-06-30

12.86%

2013-03-31

6.96%

2012-12-31

10.79%

2012-09-30

16.57%

2012-06-30

8.82%

2012-03-31

11.83%

2011-12-31

14.17%

2011-09-30

9.15%

2011-06-30

9.82%

2011-03-31

8.29%

2010-12-31

15.36%

2010-09-30

12.99%

2010-06-30

12.83%

2010-03-31

12.39%

2009-12-31

23.20%

2009-09-30

12.49%

2009-06-30

10.77%

2009-03-31

9.15%

2008-12-31

17.87%

2008-09-30

9.47%

2008-06-30

9.13%

2008-03-31

16.57%

2007-12-31

18.21%

2007-09-30

9.06%

2007-06-30

5.78%

2007-03-31

7.37%

2006-12-31

21.55%

2006-09-30

8.51%

2006-06-30

4.67%

2006-03-31

5.32%

2005-12-31

15.97%

2005-09-30

4.62%

2005-06-30

1.28%

2005-03-31

3.97%

2004-12-31

2.71%

2004-09-30

0.38%

2004-06-30

-8.23%

2004-03-31

2.88%

2003-12-31

15.98%

2003-09-30

-1.99%

2003-06-30

0.99%

2003-03-31

9.76%

2002-12-31

20.90%

2002-09-30

8.95%

EBITDA Margin: 13.28%

BRKR EBITDA Margin

BRKR Average EBITDA Margin Chart

BRKR Current vs Average EBITDA Margin Chart

BRKR EBITDA Margin Metrics

BRKR Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

BRKR EBITDA Margin History

Related Metrics